26
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Functional expression of a sodium dependent nucleoside transporter on rabbit cornea: Role in corneal permeation of acyclovir and idoxuridine

, &
Pages 175-183 | Published online: 02 Jul 2009

References

  • Cohn J, Tournoux A, Chastel C, Renard G. [Superficial herpes simplex keratitis. Double-blind comparative trial of acyclovir and idoxuridine (author's trans1)]. Nouv Presse Med. 1981;10: 2969-2970,2975.
  • la Lau C, Oosterhuis JA, Versteeg J, van Rij G, Renardel deLavalette JG, Craandijk A, Lamers WP Acyclovir and trifluorothymidine in herpetic keratitis: A multicentre trial. Br J Ophthalmol. 1982;66:506–508.
  • Laibson PR, Arentsen JJ, Mazzanti WD, Eiferman RA. Double controlled comparison of IDU and trifluorothymi-dine in thirty-three patients with superficial herpetic ker-atitis. Trans Am Ophthalmol Soc. 1977;75:316–324.
  • Lass JH, Langston RH, Foster CS, Pavan-Langston D. Antiviral medications and corneal wound healing. Antiviral Res. 1984;4:143–157.
  • Imperia PS, Lazarus HM, Dunkel EC, Pavan-Langston D, Geary PA, Lass JH. An in vitro study of ophthalmic antivi-ral agent toxicity on rabbit corneal epithelium. Antiviral Res. 1988;9:263–272.
  • Sugrue SP, Zieske JD. ZOI in corneal epithelium: Associ-ation to the zonula occludens and adherens junctions. Exp Eye Res. 1997;64:11–20.
  • Grass GM, Robinson JR. Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics. J Pharm Sci. 1988;77:3–14.
  • Grass GM, Robinson JR. Mechanisms of corneal drug pen-etration. II: Ultrastructural analysis of potential pathways for drug movement. J Pharm Sci. 1988;77:15–23.
  • Sieg JW, Robinson JR. Vehicle effects on ocular drug bioavailability. 1: Evaluation of fluorometholone. J Pharm Sci. 1975;64: 931–936.
  • Hosoya K, Horibe Y, Kim KJ, Lee VH. Nucleoside trans-port mechanisms in the pigmented rabbit conjunctiva. Invest Ophthalmol Vis Sci. 1998;39:372–377.
  • Griffith DA, Jarvis SM. Nucleoside and nucleobase trans-port systems of mammalian cells. Biochim Biophys Acta. 1996;1286:153–181.
  • Baldwin SA, Mackey JR, Cass CE, Young JD. Nucleoside transporters: Molecular biology and implications for ther-apeutic development. Mol Med Today. 1999;5:216–224.
  • Kiss A, Farah K, Kim J, Garriock RJ, Drysdale TA, Hammond JR. Molecular cloning and functional chara-cterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain. Biochem J 2000;352 Pt 2:363–372.
  • Kraupp M, Marz R. Nucleobase and nucleoside transport in mammalian cells. Wien Klin Wochenschr. 1995;107: 677–680.
  • Ward JL, Sherali A, Mo ZP, Tse CM. Kinetic and pharma-cological properties of cloned human equilibrative nucleo-side transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affin-ity for inosine. J Biol Chem. 2000;275:8375–8381.
  • Leung GP, Ward JL, Wong PY, Tse CM. Characterization of nucleoside transport systems in cultured rat epididymal epithelium. Am J Physiol Cell Physiol. 2001;280:C1076–C1082.
  • Schaner ME, Wang J, Zhang L, Su SF, Gerstin KM, Giacomini KM. Functional characterization of a human purine-selective, Na+-dependent nucleoside transporter (hSPNT1) in a mammalian expression system. J Pharma-col Exp Ther. 1999;289:1487–1491.
  • Redzic ZB, Markovic ID, Vidovic VP, Vranic VP, Gasic JM, Duricic BM, Pokrajac M, Dordevic JB, Segal MB, Rakic LM. Endogenous nucleosides in the guinea-pig eye: analysis of transport and metabolites. Exp Eye Res. 1998;66:315–325.
  • Washington CB, Giacomini KM. Mechanisms of nude-obase transport in rabbit choroid plexus: Evidence for a Na(+)-dependent nucleobase transporter with broad sub-strate selectivity. J Biol Chem. 1995;270:22816–22819.
  • Anand BS, Mitra AK. Mechanism of corneal permeation of L-valyl ester of acyclovir: Targeting the oligopeptide transporter on the rabbit cornea. Pharm Res. 2002;19: 1194–1202.
  • Anand B, Chun Y, Jain B, Mitra AK. Carrier mediated uptake of L-Tyrosine and its competitive inhibition by model tyrosine linked compounds in a rabbit corneal cell line (SIRC): Strategy for the design of transporter/receptor targeted prodrugs. Int J Pharm. 2002;247:115–125.
  • Wu S, Ann D, Lee V Molecular evidence for the existence of dipeptide transporters on the rabbit cornea and conjunc-tiva. AAPSPharmSci (supplement). 2001;3.
  • Chang SC, Bundgaard H, Buur A, Lee VH. Improved corneal penetration of timolol by prodrugs as a means to reduce systemic drug load. Invest Ophthalmol Vis Sci. 1987;28:487–491.
  • Narurkar IVIM, Mitra AK. Prodrugs of 5-iodo-2'-deoxyuridine for enhanced ocular transport. Pharm Res. 1989;6:887–891.
  • Shih RL, Lee VH. Rate limiting barrier to the penetration of ocular hypotensive beta blockers across the corneal epithelium in the pigmented rabbit. J Ocul Pharmacol. 1990;6:329–336.
  • Tak RV, Pal D, Gao H, Dey S, Mitra AK. Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line. J Pharm Sci. 2001;90: 1505–1515.
  • Gilstrap LC, Bawdon RE, Roberts SW, Sobhi S. The transfer of the nucleoside analog ganciclovir across the per-fused human placenta. Am J Obstet GynecoL 1994;170: 967–972; discussion 972–973.
  • Henderson GI, Hu ZQ, Johnson RF, Perez AB, Yang Y, Schenker S. Acyclovir transport by the human placenta. J Lab Clin Med. 1992;120:885–892.
  • Henderson GI, Hu ZQ, Yang Y, Perez TB, Devi BG, Frosto TA, Schenker S. Ganciclovir transfer by human placenta and its effects on rat fetal cells. Am J Med Sci. 1993; 306:151–156.
  • Mahony WB, Domin BA, McConnell RT, Zimmerman TR Acyclovir transport into human erythrocytes. J Biol Chem. 1988;263:9285–9291.
  • Mahony WB, Domin BA, Zimmerman TR Ganciclovir permeation of the human erythrocyte membrane. Biochem Pharmacol. 1991;41:263–271.
  • Meadows KC, Dressman JB. Mechanism of acyclovir uptake in rat jejunum. Pharm Res. 1990;7:299–303.
  • DiBona DR, Mills JIM Distribution of Na-pump sites in transporting epithelia. Fed Proc. 1979;38:134–143.
  • Defoe DM, Ahmad A, Chen W, Hughes BA. Membrane polarity of the Na(+)-K+ pump in primary cultures of Xenopus retinal pigment epithelium. Exp Eye Res. 1994;59:587–596.
  • Carrasquer G, Li M, Dinno MA. Effect of dicyclohexyl-carbodiimide (DCCD) on transport parameters in the frog cornea epithelium. J Membr Biol. 2000;174:97–103.
  • Gutierrez MiM, Giacomini KM. Substrate selectivity, potential sensitivity and stoichiometry of Na(+)-nucleoside transport in brush border membrane vesicles from human kidney. Biochim Biophys Acta. 1993;1149:202–208.
  • Wada S, Tsuda M, Sekine T, Cha SH, Kimura M, Kanai Y, Endou H. Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antivi-ral nucleoside analogs. J Pharmacol Exp Ther. 2000; 294:844–849.
  • Takeda M, Khamdang S, Narikawa S, Kimura H, Kobayashi Y, Yamamoto T, Cha SH, Sekine T, Endou H. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002;300:918–924.
  • Patil SD, Ngo LY, Unadkat JD. Structure-inhibitory profiles of nucleosides for the human intestinal Ni and N2 Na+-nucleoside transporters. Cancer Chemother Pharmacol. 2000;46: 394–402.
  • O'Brien WJ, Edelhauser HF. The corneal penetration of trifluorothymidine, adenine arabinoside, and idoxuridine: A comparative study. Invest Ophthalmol Vis Sci. 1977;16: 1093–1103.
  • Yang C, Tirucherai GS, Mitra AK. Prodrug based optimal drug delivery via membrane transporter/receptor. Expert Opin Biol Ther. 2001;1:159–175.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.